Patents by Inventor Rox Anderson

Rox Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070258906
    Abstract: The present invention relates to devices for detection and therapy of active atheromatous plaque and/or thin-capped fibro-atheroma (“vulnerable plaque”), using selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions. The present invention further relates to methods and devices for detection and therapy of active atheromatous plaques and/or vulnerable plaques, using selectively targeted beta-emitting compositions, optionally comprising fluorescent compositions.
    Type: Application
    Filed: November 16, 2006
    Publication date: November 8, 2007
    Inventors: Alan Fischman, Michael Hamblin, Ahmed Tawakol, Tayyaba Hasan, James Muller, Rox Anderson, David Elmaleh
  • Publication number: 20060073100
    Abstract: The present invention relates to methods for selectively targeting Photodynamic Therapy (“PDT”) to inflammatory components of vulnerable plaques. As such, the present invention provides methods for the identification of vulnerable plaques, using fluorescent compositions, which include photosensitizer compoisitions, and/or radiolabeled compounds, as well as methods to treat vulnerable plaques by selectively targeting and/or eliminating the inflammatory components of vulnerable plaques.
    Type: Application
    Filed: August 9, 2002
    Publication date: April 6, 2006
    Inventors: Alan Fischman, Michael Hamblin, Ahmed Tawakol, Tayyaba Hasan, James Muller, Rox Anderson, David Elmaleh, Henry Gewirtz
  • Publication number: 20030103995
    Abstract: The present invention relates to methods for selectively targeting Photodynamic Therapy (“PDT”) to inflammatory components of vulnerable plaques. As such, the present invention provides methods for the identification of vulnerable plaques, as well as methods to treat vulnerable plaques by selectively targeting and/or eliminating the inflammatory components of vulnerable plaques. The invention further relates to a specially designed intravascular device that delivers excitation light to the plaque surface inside the artery and receives emitted fluorescence light when a fluorescent signal is detected.
    Type: Application
    Filed: June 4, 2002
    Publication date: June 5, 2003
    Inventors: Michael R. Hamblin, Ahmed Tawakol, Tayaba Hassan, Alan Fischman, James Muller, Rox Anderson
  • Publication number: 20030082105
    Abstract: The present invention relates to devices for detection and therapy of active atheromatous plaque and/or thin-capped fibro-atheroma (“vulnerable plaque”), using selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions. The present invention further relates to methods and devices for detection and theraphy of active atheromatous plaques and/or vulnerable plaques, using selectively targeted beta-emitting compositions, optionally comprising fluorescent compositions.
    Type: Application
    Filed: August 9, 2002
    Publication date: May 1, 2003
    Inventors: Alan Fischman, Michael R. Hamblin, Ahmed Tawakol, Tayyaba Hasan, James Muller, Rox Anderson, David Elmaleh